| Key Financial Ratios of RPG Life Sciences (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
110.80 |
53.01 |
40.90 |
31.13 |
24.19 |
|
| Diluted EPS (Rs.) |
110.80 |
53.01 |
40.90 |
31.13 |
24.19 |
|
| Cash EPS (Rs.) |
123.76 |
63.33 |
50.27 |
40.60 |
34.15 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
320.80 |
226.67 |
186.00 |
154.66 |
130.88 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
320.80 |
226.67 |
186.00 |
154.66 |
130.88 |
|
| Dividend / Share(Rs.) |
24.00 |
16.00 |
12.00 |
9.60 |
7.20 |
|
| Revenue from Operations/Share (Rs.) |
395.12 |
351.96 |
310.09 |
266.16 |
235.31 |
|
| PBDIT/Share (Rs.) |
104.20 |
81.85 |
65.00 |
54.03 |
42.84 |
|
| PBIT/Share (Rs.) |
91.25 |
71.53 |
55.62 |
44.56 |
32.88 |
|
| PBT/Share (Rs.) |
140.82 |
71.26 |
55.44 |
44.24 |
32.40 |
|
| Net Profit/Share (Rs.) |
110.80 |
53.01 |
40.90 |
31.13 |
24.19 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
26.37 |
23.25 |
20.96 |
20.29 |
18.20 |
|
| PBIT Margin (%) |
23.09 |
20.32 |
17.93 |
16.74 |
13.97 |
|
| PBT Margin (%) |
35.63 |
20.24 |
17.87 |
16.62 |
13.76 |
|
| Net Profit Margin (%) |
28.04 |
15.06 |
13.19 |
11.69 |
10.27 |
|
| Return on Networth / Equity (%) |
34.53 |
23.38 |
21.98 |
20.12 |
18.48 |
|
| Return on Capital Employed (%) |
28.04 |
30.97 |
29.05 |
27.86 |
24.30 |
|
| Return on Assets (%) |
27.85 |
17.09 |
16.12 |
14.93 |
13.18 |
|
| Total Debt/Equity (X) |
0.00 |
0.00 |
0.00 |
0.00 |
0.01 |
|
| Asset Turnover Ratio (%) |
1.12 |
1.25 |
1.34 |
1.36 |
128.26 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
3.88 |
2.28 |
2.57 |
2.58 |
2.21 |
|
| Quick Ratio (X) |
3.11 |
1.50 |
1.64 |
1.55 |
1.47 |
|
| Inventory Turnover Ratio (X) |
1.14 |
1.23 |
0.97 |
1.25 |
6.67 |
|
| Dividend Payout Ratio (NP) (%) |
14.44 |
22.64 |
23.47 |
23.13 |
0.00 |
|
| Dividend Payout Ratio (CP) (%) |
12.92 |
18.95 |
19.10 |
17.73 |
0.00 |
|
| Earnings Retention Ratio (%) |
85.56 |
77.36 |
76.53 |
76.87 |
0.00 |
|
| Cash Earnings Retention Ratio (%) |
87.08 |
81.05 |
80.90 |
82.27 |
0.00 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
3,626.89 |
2,494.10 |
1,093.81 |
855.55 |
600.68 |
|
| EV/Net Operating Revenue (X) |
5.55 |
4.29 |
2.13 |
1.94 |
1.54 |
|
| EV/EBITDA (X) |
21.05 |
18.43 |
10.18 |
9.58 |
8.48 |
|
| MarketCap/Net Operating Revenue (X) |
5.76 |
4.35 |
2.24 |
2.10 |
1.65 |
|
| Retention Ratios (%) |
85.55 |
77.35 |
76.52 |
76.86 |
0.00 |
|
| Price/BV (X) |
7.10 |
6.75 |
3.74 |
3.62 |
2.96 |
|
| Price/Net Operating Revenue |
5.76 |
4.35 |
2.24 |
2.10 |
1.65 |
|
| Earnings Yield |
0.05 |
0.03 |
0.06 |
0.06 |
0.06 |
|
Source : Dion Global Solutions Limited
